Saltar al contenido
Slide

An understanding of disease processes drives innovation in medicine

Slide

«A thinker sees his own actions as experiments
and questions, as attempts to find out something.
Success and failure are for him answers above all.»

Slide

«There is one thing even more vital to science than intelligent
methods; and that is the sincere desire to find out the truth,
whatever it may be.»

– Charles Pierce

Slide

«Every great advance in science has issued
from a new audacity of imagination»

– John Dewey

Slide

«Somewhere, something incredible is waiting to be known»

– Carl Sagan

Slide

«There is nothing which can better deserve your patronage
than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness.»

– George Washington

Slide

«Learn from yesterday, live for today, hope for tomorrow
The important thing is to not stop questioning.»

– Albert Einstein

previous arrow
next arrow

Welcome

Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.

Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.

We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.

Follow us on Twitter to stay updated on news


SEBBM congress in Santander

SEBBM congress in Santander

Sep 14, 2018

Sept 2018 We have actively participated in the SEBBM congress in Santander Congratulations to Adrian Varela! his work on melanoma has been selected as oral presentation. María Mayán coordinator of the…

Postdoctoral Research Opportunities

Postdoctoral Research Opportunities

Abr 11, 2018

March 2017 Postdoctoral Researcher: MRC Harwell, Oxforshire, UK We are seeking a motivated and outstanding Postdoctoral candidate to join the MRC Harwell. The candidate will work with a multi-disciplinary team in…

Eppendorf Scientific Prize – SEBBM, FEBS3 AWARDS

Eppendorf Scientific Prize – SEBBM, FEBS3 AWARDS

Abr 10, 2018

Oct 2017 Best scientific image of the year, FEBS3 AWARDS The image of Marta Varela Eirín «El panal de comunicación» has been awarded  with the Eppendorf Scientific Prize in the XL…

VIII International Young Investigator Meeting

VIII International Young Investigator Meeting

Dic 28, 2017

Dic 2017 VIII International Young Investigator Meeting  INIBIC, UDC, USC and MUNCYT Coruña A Coruña, 28 December 2017 Web: http://iyimeeting2017.com/Inicio.html

New paper published in Ageing Research Reviews

New paper published in Ageing Research Reviews

Dic 21, 2017

Dic 2017 This research was performed in collaboration with Manuel Collado and José Ramón Caeiro from IDIS and Silvia Corrochano from MRC-Harwell Ageing Research Reviews Congrats Marta!

Consolidated Group A into INIBIC scientific structure

Consolidated Group A into INIBIC scientific structure

Dic 13, 2017

March 2017 Consolidated Group A into INIBIC scientific structure The CellCOM research group was established as new “associated research group” in 2015 after being evaluated by an internal committee. A few…